ClinConnect ClinConnect Logo
Search / Trial NCT06545669

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

Launched by JOHNS HOPKINS UNIVERSITY · Aug 6, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The C-Raven trial is studying a new way to help people quit smoking, particularly those living in low-income housing in Baltimore. The trial compares two groups: one group will receive a computer-based program that uses an avatar to guide them through stopping smoking, along with support from a community health worker. The other group will be placed on a waitlist and will not receive the intervention right away. The researchers want to find out how effective this program is and how well participants engage with it over six months.

To be eligible for the study, participants need to be at least 50 years old, currently smoke tobacco, and have smoked more than 100 cigarettes in their lifetime. They should also be planning to quit smoking and able to stay in their current housing for at least nine months. Participants will be asked to attend assessments at the start, one month, three months, and six months after joining the study. At three months, some participants will be interviewed to share their thoughts about the program. This trial is currently recruiting, and both men and women are welcome to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 50 or older Current tobacco use with \>100 cigarettes smoked in their lifetime
  • English speaking (intervention currently in English only and housing units are in largely English-speaking neighborhoods)
  • Considering smoking cessation
  • Planning to remain in current housing unit for 9 months
  • Exclusion Criteria:
  • Current use of pharmacological treatment for tobacco cessation
  • Contraindication to nicotine replacement therapy
  • Current engagement in formal smoking cessation program
  • Major cognitive or psychiatric impairment
  • Severe hearing impairment
  • Investigator discretion

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Alejandra Ellison-Barnes, MD

Principal Investigator

Johns Hopkins School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported